Independent · non-partisan

Advancing UK drug policy towards an evidence-based approach.

Our mission is to reduce harm, enhance public health and unlock medical and economic benefit — guided by scientific insight and a commitment to human rights.

Explore our work Read our reports
Working alongside partners across the political spectrum
12
consecutive years of rising drug deaths in England & Wales
£20bn
estimated annual cost of drug misuse to the UK economy
5,565
drug-poisoning deaths in England & Wales in 2024 — a record high
£4
returned to society for every £1 invested in drug treatment and prevention

Our workstreams

All workstreams →
01 · Drug policy governance

Reducing drug-related deaths

Advocating for evidence-based harm reduction — naloxone access, overdose prevention centres and safer consumption — after 12 consecutive years of rising fatalities.

Learn more →
02 · Medical psychedelics

The Feilding Commission

An independent body developing a UK framework for the safe, ethical and equitable rollout of psychedelic-assisted therapy.

Learn more →
03 · Kava

Honoured in the Pacific, banned in the UK

Campaigning with the UK Kava Coalition to reopen the 2002 ban so the South Pacific diaspora can access kava safely and legally.

Learn more →
The Centre's work in Parliament
Who we are

We promote evidence-based drug policy.

The Centre works on a cross-party basis to draw Parliamentarians' attention to the injustices and inadequacies of existing drug policy. We provide expert advice and briefings to government, opposition and other UK and international decision makers.

Our unique insight blends trusted, balanced evidence with political nous.

About the Centre →
“
The Centre for Evidence Based Drug Policy team is highly effective — their outcomes-driven approach gets things done. They have brought about change in the fields of psychedelics policy, reducing barriers to research, and setting reasonable phytocannabinoid limits for CBD.
Professor David Nutt
Director, Neuropsychopharmacology Unit, Imperial College London · Former chair of the UK government's Advisory Council on the Misuse of Drugs

Recent reports

All publications →
Kava report cover
Kava: Honoured in the Pacific, Banned in the UK
CEBDP · POLICY REPORT
KavaRead PDF →
Naloxone report cover
Naloxone: Legal Challenges & Opportunities for Life-Saving Intervention
CEBDP · POLICY REPORT
GovernanceRead PDF →
Psilocybin report cover
Medicinal Use of Psilocybin: Reducing Restrictions on Research
CEBDP · POLICY REPORT
PsychedelicsRead PDF →
ACMD report cover
Empowering the ACMD: Evidence-Based Solutions
CEBDP · POLICY REPORT
GovernanceRead PDF →

Latest news

April 2026Kava in the UK — the UK's first symposium on kava and kava legislation, co-hosted with Kava CoalitionKava
Sept 2025Charlotte Nichols MP launches the Feilding Commission on psychedelic-assisted therapyPsychedelics
Nov 2025Adjournment debate secured on 12 consecutive years of rising drug-related deathsGovernance

Get in touch for policy briefings, media enquiries, or to support our work.

Contact us